You just read:

Imago BioSciences Enrolls First Patient in Phase 1/2 Study of IMG-7289 in Acute Myeloid Leukemia and Myelodysplastic Syndrome

News provided by

Imago BioSciences

Nov 08, 2016, 06:00 ET